Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2013; 19(34): 5665-5670
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5665
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5665
Figure 1 Distribution of 5-aminosalicylic acid mucosal concentrations in the sigmoid colon in patients receiving oral 5-aminosalicylic acid either pH-dependent release formulations, time-dependent release formulations or prodrugs.
5-ASA: 5-aminosalicylic acid.
- Citation: D’Incà R, Paccagnella M, Cardin R, Pathak S, Baldo V, Giron MC, Sturniolo GC. 5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis. World J Gastroenterol 2013; 19(34): 5665-5670
- URL: https://www.wjgnet.com/1007-9327/full/v19/i34/5665.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i34.5665